Received Oct 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y49B2 | — |
Kinrix vaccine was administered to a 12-month-old patient; administration of Kinrix instead of Daptacel/ DTaP; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received DTPa-IPV (Kinrix) (batch number Y49B2, expiry date 17-MAY-2026) for prophylaxis. Co-suspect products included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (Daptacel) for prophylaxis. On 12-SEP-2025, the patient received Kinrix. The patient did not receive Daptacel. On 12-SEP-2025, an unknown time after receiving Kinrixl, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix vaccine was administered to a 12-month-old patient) and wrong vaccine administered (Verbatim: administration of Kinrix instead of Daptacel/ DTaP). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-SEP-2025 The patient was administration of Kinrix instead of Daptacel/ DTaP which led to wrong vaccine administered. The batch number was not provided upon follow- up with the reporter.